Wednesday, July 8, 2026
🇺🇸 FDA

biotech · Chronic Hepatitis D Virus (HDV) Infection · Chronic Hepatitis B · VIR

Vir Biotechnology

Vir Biotechnology trial registry — 38 ClinicalTrials.gov studies with program phase, status, and indication context.

Website Investor relations
1800 Owens St, Suite 900, San Francisco, California 94158, US HQ
2016 Founded
479 Employees
Public company Type
VIR · NYSE Ticker
Company details
Status
Public
HQ
1800 Owens St, Suite 900, San Francisco, California 94158, US
Founded
2016
Employees
479
Programs
34
Drugs
17
Patents
6
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Trials

Vir Biotechnology clinical trials

Registry index of 38 ClinicalTrials.gov studies linked to Vir Biotechnology programs — each row shows trial ID, program name, phase, status, and indication.

Vir Biotechnology trial registry — 38 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Vir Biotechnology.

  1. VIR-MHB1-V200 — Phase 2

    Clinical update

  2. VIR-CHDV-V206 — Phase 2

    Clinical update

  3. VIR-CHDV-V205 — Phase 3

    Clinical update

  4. VIR-5818-V101 — Phase 1

    Clinical update

  5. VIR-2218-1006 — Phase 2

    Clinical update

  6. Tenofovir Alafenamide — Phase 2

    Clinical update

  7. Sotrovimab — Phase 2

    Clinical update

  8. Bamlanivimab — Phase 2

    Clinical update

Trial registry

38 studies

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.